Patents Assigned to SYNCOM B.V.
  • Publication number: 20230144534
    Abstract: Disclosed is an advancement in provoked chemical cleavage. Thereby the invention provides the use of a diene as a chemically cleavable group attached to a Construct, and the use of a dienophile to provoke the release of the Construct by allowing the diene to react with a dienophile capable of undergoing an inverse electron demand Diels Alder reaction with the diene. The invention includes a kit for releasing a Construct CA bound to a Trigger TR, the kit having a tetrazine and a dienophile, wherein the Trigger is the tetrazine. The invention also includes the use of the formation of a pyridazine by reacting a tetrazine having a Construct CA bound thereto and a dienophile, as a chemical tool for the release, in a chemical, biological or physiological environment, of the Construct.
    Type: Application
    Filed: September 20, 2022
    Publication date: May 11, 2023
    Applicants: TAGWORKS PHARMACEUTICALS B.V., SYNCOM B.V.
    Inventors: Marc Stefan ROBILLARD, Wolter TEN HOEVE, Freek Johannes Maria HOEBEN, Ronny Mathieu VERSTEEGEN, Hendricus Marie JANSSEN, Arthur Henry Antoon Marie VAN ONZEN, Raffaella ROSSIN
  • Patent number: 11617799
    Abstract: Disclosed is an advancement in provoked chemical cleavage. Thereby the invention provides the use of a diene as a chemically cleavable group attached to a Construct, and the use of a dienophile to provoke the release of the Construct by allowing the diene to react with a dienophile capable of undergoing an inverse electron demand Diels Alder reaction with the diene. The invention includes a kit for releasing a Construct CA bound to a Trigger TR, the kit having a tetrazine and a dienophile, wherein the Trigger is the tetrazine. The invention also includes the use of the formation of a pyridazine by reacting a tetrazine having a Construct CA bound thereto and a dienophile, as a chemical tool for the release, in a chemical, biological or physiological environment, of the Construct.
    Type: Grant
    Filed: June 27, 2017
    Date of Patent: April 4, 2023
    Assignees: TAGWORKS PHARMACEUTICALS B.V., SYNCOM B.V.
    Inventors: Marc Stefan Robillard, Wolter Ten Hoeve, Freek Johannes Maria Hoeben, Ronny Mathieu Versteegen, Hendricus Marie Janssen, Arthur Henry Antoon Marie Van Onzen, Raffaella Rossin